No Picture
Trading Ideas

Morgan Stanley profit plunges as dealmaking hit by pandemic

The results capped first-quarter earnings from big U.S. banks, marked by significant declines in profit and billions in provisions to cover for a wave of expected loan defaults due to a global economic slowdown triggered by the pandemic. Morgan Stanley’s wealth management unit, which contributes roughly half of its total revenue, fell 8% to $4.04 billion, as it bore the brunt of the ongoing turmoil in financial markets. …read more […]

No Picture
Trading Ideas

Bank of America’s Quarterly Profit Almost Halves as U.S. Bank Sees Bleak Economic Outlook

Bank of America Corp. (BAC) saw its profit plunge 48% in the first three months of the year as the U.S. investment bank set aside a $3.6 billion provision for potential losses in anticipation of a deteriorating economic outlook.First-quarter pre-tax income fell to $4.5 billion, or 40 cents a share from the year-ago period. Credit loss provisions in the quarter increased to $4.8 billion from $1 billion a year ago, fueled by a $3.6 billion reserve buffer to cover for potential losses as a result of the economic impact induced by the coronavirus pandemic. Revenue slid to $22.8 million from …read more […]

No Picture
Trading Ideas

Barrick Sticks to 2020 View Even as Gold Production Sags

(Bloomberg) — Barrick Gold Corp., the world’s second-largest producer of the metal, reported the lowest quarterly production since the third quarter of 2018 but still thinks it will make its annual guidance.“These results positioned Barrick well to achieve its guidance for the year despite the impact of the global Covid-19 pandemic and the resultant lockdowns,” Barrick Chief Executive Officer Mark Bristow said Thursday in a statement.Key InsightsIn February, Barrick forecast production this year will range from 4.8 million to 5.2 million ounces.Preliminary first-quarter gold production is 1.25 million ounces of gold, Barrick said. First-quarter all-in sustaining costs for gold are …read more […]

No Picture
Trading Ideas

Novavax To Commence Australia’s First COVID-19 Vaccine Trial

As part of the urgent global race to tackle the coronavirus outbreak, Novavax (NVAX) is due to commence Phase 1 testing for its SARS-CoV-2 vaccine, NVX-CoV2373, within the coming weeks.According to the statement, this is the third confirmed global Covid-19 vaccine trial and the first in Australia.“The urgent global race to develop a vaccine against the COVID-19 pandemic drove our rapid identification and selection of an optimal, highly immunogenic vaccine candidate,” said Stanley C. Erck, President and CEO of Novavax.The Phase 1 in-human trial of NVX-CoV2373 is expected to begin in mid-May with preliminary immunogenicity and safety results in July, …read more […]